{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:29:15Z","timestamp":1649046555939},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T00:00:00Z","timestamp":1403136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099468","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T20:45:57Z","timestamp":1403210757000},"page":"e99468","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a\/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV\/HCV Genotype 1 Co-Infected Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Antonio","family":"Rivero-Juarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Torres-Cornejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ruiz-Valderas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pompeyo","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2014) Guidelines for the screening, care and treatment of persons with hepatitis C infection. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines<\/ext-link>. Accessed 2014 Apr 28."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2893.2012.01613.x","article-title":"What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behind","volume":"20","author":"F Ahmed","year":"2013","journal-title":"J Viral Hepat"},{"key":"ref3","first-page":"788","article-title":"Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus","volume":"51","author":"JA Pineda","year":"2010","journal-title":"ClinInfectDis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/QAD.0b013e328348a7ac","article-title":"Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV\/hepatitis C virus coinfected patients","volume":"25","author":"JA Pineda","year":"2011","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e61992","DOI":"10.1371\/journal.pone.0061992","article-title":"Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV\/HCV patients","volume":"8","author":"A Rivero-Juarez","year":"2013","journal-title":"PLoSOne"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1097\/01.aids.0000432459.36970.a9","article-title":"Variations at multiple genes improve interleukin 28b genotype predictive capacity for response to therapy against hepatitis c genotype 1 or 4 infection","volume":"27","author":"K Neukam","year":"2013","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2013.07.040","article-title":"Identification of Na\u00efve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin","volume":"60","author":"A Andriulli","year":"2014","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/hep.25892","article-title":"High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials","volume":"56","author":"P Marcellin","year":"2012","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jinf.2013.11.009","article-title":"Sustained virological response in HIV\/HCV co-infected patients treated with pegylated interferon\/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy","volume":"68","author":"A Rivero-Juarez","year":"2014","journal-title":"J Infection"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2011.12.026","article-title":"Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin","volume":"56","author":"P Marcellin","year":"2012","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/MEG.0b013e328362797b","article-title":"Sustained virological response based on the week 4 response in hepatitis C virus genotype 1 patients treated with peginterferons \u03b1-2a and \u03b1-2b, plus ribavirin","volume":"25","author":"UB Dogan","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, Management and Treatment of Hepatitis C: An update. AASLD PracticeGuidelines","volume":"49","author":"MG Ghany","year":"2009","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1086\/521857","article-title":"The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection","volume":"45","author":"S Vergara","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2012.09.023","article-title":"Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?","volume":"58","author":"A Pascale","year":"2013","journal-title":"J Hepatol"},{"key":"ref15","first-page":"71","article-title":"Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon\/ribavirin obviates a protease inhibitor.Hepatology","volume":"59","author":"BL Pearlman","year":"2014"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jinf.2013.03.010","article-title":"Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response","volume":"67","author":"K Neukam","year":"2013","journal-title":"J Infect"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:07:30Z","timestamp":1588982850000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099468"}},"subtitle":[],"editor":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099468","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}